Jet Lag Relief NDC 0220-9214

NDC codes

FDA NDC Directory

Product NDC (as listed)0220-9214Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00220-9214Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0220-9214-43	00220921443	3 TUBE in 1 PACKAGE (0220-9214-43) / 80 PELLET in 1 TUBEMarketed from Jan 1, 2017

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Jet Lag Relief
Generic name (nonproprietary): anamirta cocculus seed, arnica montana, strychnos nux-vomica whole
Active ingredients: Anamirta cocculus seed — 6 [hp_C]/1Arnica montana — 6 [hp_C]/1Strychnos nux-vomica whole — 30 [hp_C]/1
Dosage form: Pellet
Route: Oral
Labeler: Laboratoires Boiron
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Jan 1, 2017
Listing expires: Dec 31, 2026
Identifiers: Product ID 0220-9214_06ea4a82-ecae-6320-e063-6394a90ab9a0SPL ID 06ea4a82-ecae-6320-e063-6394a90ab9a0SPL set ID 419781a0-bf70-11e7-81f3-424c58303031UNII 810258W28U, O80TY208ZW, AB2NX17POSUPC 0306969214435, 0000700000218

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400220921443 followed by a unit qualifier and the quantity

Package 00220-9214-43. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 4, 2023.

Indications (excerpt from the label)

Uses* temporarily relieves symptoms such as: nausea stiffness muscle pain drowsiness

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)